Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
1.7K
Total Open
Publications
830
Total
Citations
53K
Open Access
Percentage
49%
Total
Publications
1.7K
Total Open
Publications
830
Total
Citations
53K
Breakdown
Publisher Open
17%
Both
28%
Other Platform Open
4%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
230
Hybrid 46%
344
No Guarantees 23%
177
Other Platform Open
Domain 82%
450
Institution 15%
83
Other Internet 15%
82
Public 2%
13
Preprint 0%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 449 |
DOI | Other Internet | 82 |
Europe PMC | Domain | 30 |
Royal Netherlands Academy of Arts and Sciences | Institution | 15 |
Harris County Public Library | Institution | 15 |
Figshare | Public | 13 |
University of Southern Denmark | Institution | 5 |
Washington University in St. Louis | Institution | 4 |
KU Leuven | Institution | 4 |
University of Michigan–Ann Arbor | Institution | 3 |